Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges.
Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges.
复制标题
DOI:
10.3390/pharmaceutics15010237
复制
发表时间:
2023-01-10
期刊:
影响因子:
5.4
通讯作者:
Jones SW
中科院分区:
文献类型:
--
作者:
Nicholson TA;Sagmeister M;Wijesinghe SN;Farah H;Hardy RS;Jones SW
Age-related disorders of the musculoskeletal system including sarcopenia, osteoporosis and arthritis represent some of the most common chronic conditions worldwide, for which there remains a great clinical need to develop safer and more efficacious pharmacological treatments. Collectively, these conditions involve multiple tissues, including skeletal muscle, bone, articular cartilage and the synovium within the joint lining. In this review, we discuss the potential for oligonucleotide therapies to combat the unmet clinical need in musculoskeletal disorders by evaluating the successes of oligonucleotides to modify candidate pathological gene targets and cellular processes in relevant tissues and cells of the musculoskeletal system. Further, we discuss the challenges that remain for the clinical development of oligonucleotides therapies for musculoskeletal disorders and evaluate some of the current approaches to overcome these.
登录
查看更多内容
影响因子:
3.7
作者:
Castillero E;Alamdari N;Aversa Z;Gurav A;Hasselgren PO
通讯作者:
Hasselgren PO
影响因子:
14.9
作者:
Anderson BA;Freestone GC;Low A;De-Hoyos CL;Iii WJD;Østergaard ME;Migawa MT;Fazio M;Wan WB;Berdeja A;Scandalis E;Burel SA;Vickers TA;Crooke ST;Swayze EE;Liang X;Seth PP
通讯作者:
Seth PP
影响因子:
4.3
作者:
Drake, Matthew T.
通讯作者:
Drake, Matthew T.
影响因子:
--
作者:
Crofford, LJ;Tan, B;Hla, T
通讯作者:
Hla, T
影响因子:
14.6
作者:
Berger, Claudie;Langsetmo, Lisa;Goltzman, David
通讯作者:
Goltzman, David